Breast Cancer News and Research

Latest Breast Cancer News and Research

Nanoparticles with chemotherapeutic drugs can kill drug-resistant breast cancer cells

Nanoparticles with chemotherapeutic drugs can kill drug-resistant breast cancer cells

Researchers identify enzymes that are crucial for growth of cancers with genetic aberrations in p53

Researchers identify enzymes that are crucial for growth of cancers with genetic aberrations in p53

MU researchers find more accurate laboratory method for diagnosing pancreatic cancer

MU researchers find more accurate laboratory method for diagnosing pancreatic cancer

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

AMGA honors Mid-Atlantic Permanente Medical Group with Acclaim Award

AMGA honors Mid-Atlantic Permanente Medical Group with Acclaim Award

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

Researchers use machine learning approach to accurately diagnose breast cancer

Researchers use machine learning approach to accurately diagnose breast cancer

The Princess Margaret Cancer Foundation launches innovative Fall advertising campaign

The Princess Margaret Cancer Foundation launches innovative Fall advertising campaign

Nanomedicine Award winners officially announced at BIO-Europe conference

Nanomedicine Award winners officially announced at BIO-Europe conference

Gene sequencing reveals mutations in estrogen receptor

Gene sequencing reveals mutations in estrogen receptor

Obesity is largest predictor of earlier onset puberty in girls, shows research

Obesity is largest predictor of earlier onset puberty in girls, shows research

IOF outlines guidelines to help prevent osteoporosis and fractures in cancer patients

IOF outlines guidelines to help prevent osteoporosis and fractures in cancer patients

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Eliza's Star multi-modal programs address gaps in healthcare

Eliza's Star multi-modal programs address gaps in healthcare

Meta-analysis shows that XRCC1 Arg399Gln polymorphism may be a biomarker of glioma susceptibility

Meta-analysis shows that XRCC1 Arg399Gln polymorphism may be a biomarker of glioma susceptibility

Unrealistic pessimists less likely to take preventive action after receiving good news

Unrealistic pessimists less likely to take preventive action after receiving good news

Study finds links between breast cancer radiation and long-term cardiovascular-related deaths

Study finds links between breast cancer radiation and long-term cardiovascular-related deaths

Study reveals that specific protein may assist breast cancer cells in metastasizing

Study reveals that specific protein may assist breast cancer cells in metastasizing

Self-directed walking program shows promise in easing joint stiffness in older breast cancer patients

Self-directed walking program shows promise in easing joint stiffness in older breast cancer patients

McGill online game expands to connect global scientific community with citizen scientists

McGill online game expands to connect global scientific community with citizen scientists

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.